Moderna COVID-19 vaccine: Continued monitoring

At the time of authorization, no major safety concerns have been reported in the available data submitted to Health Canada. We are carefully monitoring the post-market (after authorization) safety and effectiveness of authorized COVID-19 vaccines. As part of our commitment to keep Canadians informed, we are publishing information about adverse events following immunization (AEFI).

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-07-29

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data